Integra LifeSciences Holdings Corporation Announces the Release of the PANTA XL Arthrodesis Nail

PLAINSBORO, N.J., Aug. 7, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the release of the Panta(R) XL Arthrodesis Nail, a solution for tibiotalocalcaneal (TTC) arthrodesis. The Panta(R) XL Nail has received clearance from the U.S. Food and Drug Administration (FDA) and a CE Mark Certification in the European Union.
MORE ON THIS TOPIC